165 related articles for article (PubMed ID: 21990342)
41. AroER tri-screen™ is a novel functional assay to estimate both estrogenic and estrogen precursor activity of chemicals or biological specimens.
Kanaya N; Nguyen DM; Lu H; Wang YZ; Hsin LY; Petreas M; Nelson D; Guo W; Reynolds P; Synold T; Chen S
Breast Cancer Res Treat; 2015 Jun; 151(2):335-45. PubMed ID: 25962693
[TBL] [Abstract][Full Text] [Related]
42. Predicting health effects of exposures to compounds with estrogenic activity: methodological issues.
Rudel R
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):655-63. PubMed ID: 9168010
[TBL] [Abstract][Full Text] [Related]
43. Assessing developmental toxicity and estrogenic activity of halogenated bisphenol A on zebrafish (Danio rerio).
Song M; Liang D; Liang Y; Chen M; Wang F; Wang H; Jiang G
Chemosphere; 2014 Oct; 112():275-81. PubMed ID: 25048916
[TBL] [Abstract][Full Text] [Related]
44. A low-density DNA microchip for the detection of (anti-)estrogenic compounds and their relative potencies.
Wang S; Rijk JC; Pen MJ; Aarts JM; Peijnenburg AA; Rietjens IM; Bovee TF
Anal Biochem; 2013 Apr; 435(1):83-92. PubMed ID: 23296041
[TBL] [Abstract][Full Text] [Related]
45. Differential effects of esculetin and daphnetin on in vitro cell proliferation and in vivo estrogenicity.
Jiménez-Orozco FA; Rosales AA; Vega-López A; Domínguez-López ML; García-Mondragón MJ; Maldonado-Espinoza A; Lemini C; Mendoza-Patiño N; Mandoki JJ
Eur J Pharmacol; 2011 Oct; 668(1-2):35-41. PubMed ID: 21741969
[TBL] [Abstract][Full Text] [Related]
46. Quantitative comparisons of in vitro assays for estrogenic activities.
Fang H; Tong W; Perkins R; Soto AM; Prechtl NV; Sheehan DM
Environ Health Perspect; 2000 Aug; 108(8):723-9. PubMed ID: 10964792
[TBL] [Abstract][Full Text] [Related]
47. Performance of the flow cytometric E-screen assay in screening estrogenicity of pure compounds and environmental samples.
Vanparys C; Depiereux S; Nadzialek S; Robbens J; Blust R; Kestemont P; De Coen W
Sci Total Environ; 2010 Sep; 408(20):4451-60. PubMed ID: 20633926
[TBL] [Abstract][Full Text] [Related]
48. Short-term effects of endocrine-disrupting chemicals on the expression of estrogen-responsive genes in male medaka (Oryzias latipes).
Yamaguchi A; Ishibashi H; Kohra S; Arizono K; Tominaga N
Aquat Toxicol; 2005 Apr; 72(3):239-49. PubMed ID: 15820104
[TBL] [Abstract][Full Text] [Related]
49. Effects of environmental estrogenic chemicals on AP1 mediated transcription with estrogen receptors alpha and beta.
Fujimoto N; Kitamura S
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):53-9. PubMed ID: 15026083
[TBL] [Abstract][Full Text] [Related]
50. Effects of triclocarban on the transcription of estrogen, androgen and aryl hydrocarbon receptor responsive genes in human breast cancer cells.
Tarnow P; Tralau T; Hunecke D; Luch A
Toxicol In Vitro; 2013 Aug; 27(5):1467-75. PubMed ID: 23524099
[TBL] [Abstract][Full Text] [Related]
51. Flow cytometric cell cycle analysis allows for rapid screening of estrogenicity in MCF-7 breast cancer cells.
Vanparys C; Maras M; Lenjou M; Robbens J; Van Bockstaele D; Blust R; De Coen W
Toxicol In Vitro; 2006 Oct; 20(7):1238-48. PubMed ID: 16797915
[TBL] [Abstract][Full Text] [Related]
52. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
53. Amphibians as a model to study endocrine disruptors: II. Estrogenic activity of environmental chemicals in vitro and in vivo.
Kloas W; Lutz I; Einspanier R
Sci Total Environ; 1999 Jan; 225(1-2):59-68. PubMed ID: 10028703
[TBL] [Abstract][Full Text] [Related]
54. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals.
Roy D; Palangat M; Chen CW; Thomas RD; Colerangle J; Atkinson A; Yan ZJ
J Toxicol Environ Health; 1997 Jan; 50(1):1-29. PubMed ID: 9015129
[TBL] [Abstract][Full Text] [Related]
55. Mixture effects of estrogenic compounds on proliferation and pS2 expression of MCF-7 human breast cancer cells.
van Meeuwen JA; Ter Burg W; Piersma AH; van den Berg M; Sanderson JT
Food Chem Toxicol; 2007 Nov; 45(11):2319-30. PubMed ID: 17651883
[TBL] [Abstract][Full Text] [Related]
56. Experimental and computational insights on the recognition mechanism between the estrogen receptor α with bisphenol compounds.
Cao H; Wang F; Liang Y; Wang H; Zhang A; Song M
Arch Toxicol; 2017 Dec; 91(12):3897-3912. PubMed ID: 28616630
[TBL] [Abstract][Full Text] [Related]
57. Estrogen receptor independent rapid non-genomic effects of environmental estrogens on [Ca2+]i in human breast cancer cells.
Walsh DE; Dockery P; Doolan CM
Mol Cell Endocrinol; 2005 Jan; 230(1-2):23-30. PubMed ID: 15664448
[TBL] [Abstract][Full Text] [Related]
58. Toxicity, dioxin-like activities, and endocrine effects of DDT metabolites--DDA, DDMU, DDMS, and DDCN.
Wetterauer B; Ricking M; Otte JC; Hallare AV; Rastall A; Erdinger L; Schwarzbauer J; Braunbeck T; Hollert H
Environ Sci Pollut Res Int; 2012 Feb; 19(2):403-15. PubMed ID: 21792584
[TBL] [Abstract][Full Text] [Related]
59. Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters.
Minervini F; Giannoccaro A; Cavallini A; Visconti A
Toxicol Lett; 2005 Dec; 159(3):272-83. PubMed ID: 15994033
[TBL] [Abstract][Full Text] [Related]
60. MVLN cells: a bioluminescent MCE-7-derived cell line to study the modulation of estrogenic activity.
Demirpence E; Duchesne MJ; Badia E; Gagne D; Pons M
J Steroid Biochem Mol Biol; 1993 Sep; 46(3):355-64. PubMed ID: 9831484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
